These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34063514)

  • 1. Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study.
    Santos AR; Mendes L; Madeira MH; Marques IP; Tavares D; Figueira J; Lobo C; Cunha-Vaz J
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34063514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression.
    Marques IP; Madeira MH; Messias AL; Martinho AC; Santos T; Sousa DC; Figueira J; Cunha-Vaz J
    Acta Diabetol; 2021 Feb; 58(2):197-205. PubMed ID: 33025221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microaneurysm turnover is a predictor of diabetic retinopathy progression.
    Pappuru RKR; Ribeiro L; Lobo C; Alves D; Cunha-Vaz J
    Br J Ophthalmol; 2019 Feb; 103(2):222-226. PubMed ID: 29699981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
    Ribeiro L; Bandello F; Tejerina AN; Vujosevic S; Varano M; Egan C; Sivaprasad S; Menon G; Massin P; Verbraak FD; Lund-Andersen H; Martinez JP; Jürgens I; Smets E; Coriat C; Wiedemann P; Ágoas V; Querques G; Holz FG; Nunes S; Neves C; Cunha-Vaz J;
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5698-705. PubMed ID: 26322834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microaneurysm count as a predictor of long-term progression in diabetic retinopathy in young patients with type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).
    Rasmussen ML; Broe R; Frydkjaer-Olsen U; Olsen BS; Mortensen HB; Peto T; Grauslund J
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):199-205. PubMed ID: 24898428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.
    Marques IP; Madeira MH; Messias AL; Santos T; Martinho AC; Figueira J; Cunha-Vaz J
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32408522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Handheld Retinal Imaging with ETDRS 7-Standard Field Photography for Diabetic Retinopathy and Diabetic Macular Edema.
    Salongcay RP; Aquino LAC; Salva CMG; Saunar AV; Alog GP; Sun JK; Peto T; Silva PS
    Ophthalmol Retina; 2022 Jul; 6(7):548-556. PubMed ID: 35278726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.
    Ribeiro ML; Nunes SG; Cunha-Vaz JG
    Diabetes Care; 2013 May; 36(5):1254-9. PubMed ID: 23204247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease.
    Madeira MH; Marques IP; Ferreira S; Tavares D; Santos T; Santos AR; Figueira J; Lobo C; Cunha-Vaz J
    Front Neurosci; 2021; 15():800004. PubMed ID: 35757010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhage and/or Microaneurysm Severity and Count in Ultrawide Field Images and Early Treatment Diabetic Retinopathy Study Photography.
    Silva PS; El-Rami H; Barham R; Gupta A; Fleming A; van Hemert J; Cavallerano JD; Sun JK; Aiello LP
    Ophthalmology; 2017 Jul; 124(7):970-976. PubMed ID: 28336057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate for diabetic retinopathy.
    Kataoka SY; Lois N; Kawano S; Kataoka Y; Inoue K; Watanabe N
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013318. PubMed ID: 37310870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy.
    Silva PS; Cavallerano JD; Sun JK; Noble J; Aiello LM; Aiello LP
    Am J Ophthalmol; 2012 Sep; 154(3):549-559.e2. PubMed ID: 22626617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Progression of Nonproliferative Diabetic Retinopathy Using Non-Invasive Imaging.
    Marques IP; Ribeiro ML; Santos T; Reste-Ferreira D; Mendes L; Martinho AC; Santos AR; Figueira J; Lobo C; Cunha-Vaz J
    Transl Vis Sci Technol; 2024 May; 13(5):22. PubMed ID: 38780953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choriocapillaris Flow Deficit as a Biomarker for Diabetic Retinopathy and Diabetic Macular Edema: 3-Year Longitudinal Cohort.
    Chen Y; Zhu Z; Cheng W; Bulloch G; Chen Y; Liao H; Li Y; Liang X; Huang W; He M; Wang W;
    Am J Ophthalmol; 2023 Apr; 248():76-86. PubMed ID: 36436548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy.
    Ribeiro L; Marques IP; Coimbra R; Santos T; Madeira MH; Santos AR; Barreto P; Lobo C; Cunha-Vaz J
    Ophthalmol Ther; 2022 Feb; 11(1):333-345. PubMed ID: 34865186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
    Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
    JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.
    Haritoglou C; Kernt M; Neubauer A; Gerss J; Oliveira CM; Kampik A; Ulbig M
    Retina; 2014 Jan; 34(1):157-64. PubMed ID: 23792485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Assessment of the Severity of Diabetic Retinopathy.
    Sadda SR; Nittala MG; Taweebanjongsin W; Verma A; Velaga SB; Alagorie AR; Sears CM; Silva PS; Aiello LP
    Am J Ophthalmol; 2020 Oct; 218():342-352. PubMed ID: 32446737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy.
    Nunes S; Pires I; Rosa A; Duarte L; Bernardes R; Cunha-Vaz J
    Ophthalmologica; 2009; 223(5):292-7. PubMed ID: 19372723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.